Back
Citius Pharmaceuticals Vs. Agilent Technologies Industry Stock Comparison
Buy
63
CTXR
Citius Pharmaceuticals
Last Price:
0.39
Seasonality Move:
21.66%
Sell
41
A
Agilent Technologies
Last Price:
134.40
Seasonality Move:
8.09%
Buy
63
Citius Pharmaceuticals (CTXR)
is a Buy
Is Citius Pharmaceuticals a Buy, Sell or Hold?
- The current Citius Pharmaceuticals [CTXR] share price is $0.48. The Score for CTXR is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
- CTXR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
41
Agilent Technologies (A)
is a Sell
Is Agilent Technologies a Buy, Sell or Hold?
- The current Agilent Technologies [A] share price is $133.67. The Score for A is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
- A is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CTXR Stock Price Chart
What is Citius Pharmaceuticals's stock price today?
-
The Citius Pharmaceuticals share price today is $0.48
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CTXR is experiencing slight selling pressure.
A Stock Price Chart
What is Agilent Technologies's stock price today?
-
The Agilent Technologies share price today is $133.67
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and A is experiencing selling pressure, which indicates risk of future bearish movement.
CTXR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 64.05 | Buy |
| Chaikin Money Flow: | -564264 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.35 - 0.41) | Buy |
| Bollinger Bands (100): | (0.4 - 0.76) | Sell |
A Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.12 | Sell |
| Relative Strength Index (14 RSI): | 42.92 | Sell |
| Chaikin Money Flow: | -1356914 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (132.24 - 142.16) | Sell |
| Bollinger Bands (100): | (131.84 - 142.48) | Sell |
CTXR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.39 | Buy |
| 20-day SMA: | 0.38 | Buy |
| 50-day SMA: | 0.44 | Buy |
| 200-day SMA: | 0.66 | Sell |
| 8-day EMA: | 0.41 | Buy |
| 20-day EMA: | 0.4 | Buy |
| 50-day EMA: | 0.45 | Buy |
| 200-day EMA: | 0.63 | Sell |
A Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 137.32 | Sell |
| 20-day SMA: | 135.49 | Sell |
| 50-day SMA: | 139.2 | Sell |
| 200-day SMA: | 138.61 | Sell |
| 8-day EMA: | 135.75 | Sell |
| 20-day EMA: | 136.58 | Sell |
| 50-day EMA: | 137.98 | Sell |
| 200-day EMA: | 136.62 | Sell |
Citius Pharmaceuticals Earnings Growth & CTXR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.02 per share, and an increase next year of $0.33 per share.
Agilent Technologies Earnings Growth & A Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.17 per share, and an increase next year of $0.42 per share.
Citius Pharmaceuticals Technical Analysis
| Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Agilent Technologies Technical Analysis
| Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||